CONMED (CNMD) Earnings Date, Estimates & Call Transcripts $57.85 -2.58 (-4.27%) Closing price 03:58 PM EasternExtended Trading$57.90 +0.04 (+0.07%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CONMED Latest Earnings SummaryUpcoming Q1 Earnings DateApr. 23After Market ClosesEstimatedActual EPS (Feb. 5) $1.34 Beat By $0.14 Consensus EPS (Feb. 5) $1.20 CONMED released Q4 2024 earnings on February 5, 2025, reporting an EPS of $1.34, which topped analysts' consensus estimates of $1.20 by $0.14. With a trailing EPS of $4.24 and a P/E Ratio of 13.64, CONMED's earnings are expected to grow 16.55% next year, from $4.35 to $5.07 per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by CNMD Upcoming EarningsCONMED's next earnings date is estimated for Wednesday, April 23, 2025, based off prior year's reporting schedules, with a conference call scheduled for at 4:30 PM ET. Interested parties can register for or listen to the call. Get CONMED Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CONMED and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCNMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CNMD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads CONMED Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20251$1.26$1.26$1.26 Q2 20251$1.28$1.28$1.28 Q3 20251$1.46$1.46$1.46 Remove Ads CONMED Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/23/2025(Estimated)-------2/5/2025Q4 2024$1.20$1.34+$0.14$1.08$341.05M-10/30/2024Q3 2024$0.99$1.05+$0.06$0.53$318.46M$316.70M7/31/2024Q2 2024$0.92$0.98+$0.06$1.00$334.39M$332.10M4/24/2024Q1 2024$0.74$0.79+$0.05$0.95$307.06M$312.27M1/31/2024Q4 2023$1.11$1.06 -$0.05$1.07$332.94M$327.05M10/25/2023Q3 2023$0.83$0.90+$0.07$1.30$301.22M$304.58M7/26/2023Q2 2023$0.79$0.83+$0.04$1.23$306.15M$317.70M4/26/2023Q1 2023$0.60$0.66+$0.06$1.26$266.66M$295.47M CONMED Earnings - Frequently Asked Questions When is CONMED's earnings date? CONMED has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 23rd, 2025 based off last year's report dates. Learn more on CNMD's earnings history. What guidance has CONMED issued on next quarter's earnings? CONMED issued an update on its FY 2025 earnings guidance on Wednesday, February, 5th. The company provided earnings per share (EPS) guidance of 4.250-4.400 for the period, compared to the consensus EPS estimate of 4.740. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Did CONMED beat their earnings estimates last quarter? In the previous quarter, CONMED (NYSE:CNMD) reported $1.34 earnings per share (EPS) to beat the analysts' consensus estimate of $1.20 by $0.14. Learn more on analysts' earnings estimate vs. CNMD's actual earnings. How can I listen to CONMED's earnings conference call? The conference call for CONMED's latest earnings report can be listened to online. Listen to Conference Call How can I read CONMED's conference call transcript? The conference call transcript for CONMED's latest earnings report can be read online. Read Transcript How much revenue does CONMED generate each year? CONMED (NYSE:CNMD) has a recorded annual revenue of $1.31 billion. How much profit does CONMED generate each year? CONMED (NYSE:CNMD) has a recorded net income of $132.42 million. CNMD has generated $4.24 earnings per share over the last four quarters. What is CONMED's price-to-earnings ratio? CONMED (NYSE:CNMD) has a trailing price-to-earnings ratio of 13.64 and a forward price-to-earnings ratio of 13.30. The price/earnings-to-growth ratio is 1.83. What is CONMED's EPS forecast for next year? CONMED's earnings are expected to grow from $4.35 per share to $5.07 per share in the next year, which is a 16.55% increase. More Earnings Resources from MarketBeat Related Companies Stevanato Group Earnings Results Glaukos Earnings Results Bausch + Lomb Earnings Results Inspire Medical Systems Earnings Results Inari Medical Earnings Results iRhythm Technologies Earnings Results Soleno Therapeutics Earnings Results PROCEPT BioRobotics Earnings Results Envista Earnings Results TransMedics Group Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio? Remove Ads This page (NYSE:CNMD) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
